Publicacións en colaboración con investigadores/as de Cedars-Sinai Medical Center (18)

2024

  1. Author Correction: Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement (Nature Reviews Endocrinology, (2023), 19, 12, (722-740), 10.1038/s41574-023-00886-5)

    Nature Reviews Endocrinology

  2. Consensus on criteria for acromegaly diagnosis and remission

    Pituitary, Vol. 27, Núm. 1, pp. 7-22

  3. Correction: consensus on criteria for acromegaly diagnosis and remission (Pituitary, (2024), 27, 1, (7-22), 10.1007/s11102-023-01360-1)

    Pituitary

  4. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial

    Circulation: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 457-473

2023

  1. Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement

    Nature Reviews Endocrinology, Vol. 19, Núm. 12, pp. 722-740

2021

  1. Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time?

    Journal of the Endocrine Society, Vol. 5, Núm. 3

2019

  1. Staging and managing patients with acromegaly in clinical practice: baseline data from the SAGIT® validation study

    Pituitary, Vol. 22, Núm. 5, pp. 476-487

  2. World Workshop on Oral Medicine VII: Non-opioid pain management of head and neck chemo/radiation-induced mucositis: A systematic review

    Oral Diseases, Vol. 25, Núm. S1, pp. 182-192

2018

  1. Correction to: Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement (Pituitary, (2017), 20, 5, (489-498), 10.1007/s11102-017-0838-2)

    Pituitary

2017

  1. Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement

    Pituitary, Vol. 20, Núm. 5, pp. 489-498

  2. Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials

    Arthritis and Rheumatology, Vol. 69, Núm. 2, pp. 362-375

  3. The oncoarray consortium: A network for understanding the genetic architecture of common cancers

    Cancer Epidemiology Biomarkers and Prevention, Vol. 26, Núm. 1, pp. 126-135

2016

  1. Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations

    European Journal of Endocrinology

  2. SAGIT®: clinician-reported outcome instrument for managing acromegaly in clinical practice—development and results from a pilot study

    Pituitary, Vol. 19, Núm. 1, pp. 39-49

  3. Ustekinumab as induction and maintenance therapy for Crohn's disease

    New England Journal of Medicine, Vol. 375, Núm. 20, pp. 1946-1960

2011

  1. Diagnosis and treatment of hyperprolactinemia: An endocrine society clinical practice guideline

    Journal of Clinical Endocrinology and Metabolism, Vol. 96, Núm. 2, pp. 273-288

2002

  1. Consensus: Guidelines for acromegaly management

    Journal of Clinical Endocrinology and Metabolism

2000

  1. Criteria for cure of acromegaly: A consensus statement

    Journal of Clinical Endocrinology and Metabolism, Vol. 85, Núm. 2, pp. 526-529